Science Translational Medicine
19 January 2011 vol 3, issue 66
http://stm.sciencemag.org/content/current

Commentary
Policy
“Creating Hope” and Other Incentives for Drug Development for Children
Edward Connor and Pablo Cure
19 January 2011: 66cm1

Abstract
Enhancing drug development for pediatric disease is a priority and a public responsibility. The Creating Hope Act of 2010 is important new proposed legislation that adds drugs and biologics for treating rare diseases in children to those for neglected tropical diseases as eligible for a priority review voucher from the U.S. Food and Drug Administration. The Act enhances existing incentive programs through specific financial benefits to companies who seek a pediatric indication for a new drug to treat an orphan disease that occurs specifically in children.